10 results
10-K
2020 FY
NEXI
Neximmune Inc
31 Mar 21
Annual report
4:02pm
are then introduced into culture with the CD8+ T cells and run through a magnetic column. The magnetic properties of the SPIO core enable the magnetic field … to separate, or “enrich”, antigen-specific CD8+ T cells from those that are not specific to the antigen peptides of interest. The enriched culture
424B4
NEXI
Neximmune Inc
16 Feb 21
Prospectus supplement with pricing info
4:38pm
not be able to realize the benefit of such transactions if we are unable to successfully integrate them with our existing operations and company culture, which … mononuclear cells, or PBMCs. Aliquots of individual antigen peptide-loaded AIM nanoparticles are then introduced into culture with the CD8+ T cells and run
S-1/A
qvs7j2bgzjaesvo2lk0
8 Feb 21
IPO registration (amended)
7:29am
S-1
1j8jt10i2ntfhqv0awx
19 Jan 21
IPO registration
4:38pm
DRS/A
zm23phettg q4io4b
15 Jan 21
Draft registration statement (amended)
12:00am
DRS
wpdcuh
14 Dec 20
Draft registration statement
12:00am
- Prev
- 1
- Next